海蘭信(300065.SZ)一季度預虧1840萬元至1360萬元
格隆匯4月10日丨海蘭信(300065.SZ)發佈2020年度第一季度業績預告,報告期內,預計歸屬於上市公司股東的淨利潤介於-1840.00萬元至-1360.00萬元,上年同期為2922.41萬元。
受疫情影響,一季度2至3月期間,主要客户單位及公司武漢基地未能復工,影響公司及時交付貨物以及收入確認。
疫情期間公司積極應對,主動作為,公司與團隊捐贈給武漢抗擊疫情一線醫護人員防護服等物資累計金額420餘萬元;同時加強與客户溝通,保障重點項目的實施進度;通過提升遠程辦公支持能力,保證研發工作按計劃進行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.